Ignite Creation Date:
2025-12-24 @ 2:44 PM
Ignite Modification Date:
2026-01-01 @ 1:33 PM
Study NCT ID:
NCT01821859
Status:
TERMINATED
Last Update Posted:
2013-07-26
First Post:
2013-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Abraxane/Bevacizumab
Sponsor:
OHSU Knight Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-01
Start Date Type:
None
Primary Completion Date:
2011-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-11
Completion Date Type:
ACTUAL
First Submit Date:
2013-03-27
First Submit QC Date:
None
Study First Post Date:
2013-04-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-04-01
Results First Submit QC Date:
None
Results First Post Date:
2013-05-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-07-18
Last Update Post Date:
2013-07-26
Last Update Post Date Type:
ESTIMATED